Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful management of doxorubicin overdose and extravasation in a dog with lymphoma.

Literature DB >> 30510312

Successful management of doxorubicin overdose and extravasation in a dog with lymphoma.

Kristin S Kicenuik¹, Nicole C Northrup¹, Dawn M Clarke¹, Lisa J Bazzle¹.

Abstract

A dog was hospitalized after accidental overdose and extravasation of doxorubicin. With supportive care and dexrazoxane, systemic toxicity resolved by Day 9 and extravasation injury by Day 36. This case demonstrates that, with treatment, dogs can survive doxorubicin overdose and extravasation. The report also highlights the importance of checking the dose of chemotherapeutic agents and preventing extravasation.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2018 PMID： 30510312 PMCID： PMC6135299

Source DB: PubMed Journal: Can Vet J ISSN： 0008-5286 Impact factor: 1.008

27 in total

1. Hematologic improvement in dogs with parvovirus infection treated with recombinant canine granulocyte-colony stimulating factor.

Authors: A Duffy; S Dow; G Ogilvie; S Rao; T Hackett
Journal: J Vet Pharmacol Ther Date: 2010-08 Impact factor: 1.786

2. Acute doxorubicin overdoses.

Authors: C F Curran
Journal: Ann Intern Med Date: 1991-12-01 Impact factor: 25.391

3. Veterinary cooperative oncology group - common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1.

Authors:
Journal: Vet Comp Oncol Date: 2016-12 Impact factor: 2.613

4. Long-term clinical outcome after accidental overdose of multiple chemotherapeutic agents.

Authors: Aytug Uner; Ahmet Ozet; Fikret Arpaci; Diclehan Unsal
Journal: Pharmacotherapy Date: 2005-07 Impact factor: 4.705

5. Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies.

Authors: H T Mouridsen; S W Langer; J Buter; H Eidtmann; G Rosti; M de Wit; P Knoblauch; A Rasmussen; K Dahlstrøm; P B Jensen; G Giaccone
Journal: Ann Oncol Date: 2006-12-21 Impact factor: 32.976

6. Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial.

Authors: R García-Carbonero; J I Mayordomo; M V Tornamira; M López-Brea; A Rueda; V Guillem; A Arcediano; A Yubero; F Ribera; C Gómez; A Trés; J L Pérez-Gracia; C Lumbreras; J Hornedo; H Cortés-Funes; L Paz-Ares
Journal: J Natl Cancer Inst Date: 2001-01-03 Impact factor: 13.506

7. Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)--a Veterinary Cooperative Oncology Group (VCOG) consensus document.

Authors: D M Vail; G M Michels; C Khanna; K A Selting; C A London
Journal: Vet Comp Oncol Date: 2010-03 Impact factor: 2.613

2. Pharmacokinetic study comparing doxorubicin concentrations after chemoembolization or intravenous administration in dogs with naturally occurring nonresectable hepatic carcinoma.

Authors: Nina Samuel; Chick Weisse; Allyson C Berent; Cléo P Rogatko; Luke Wittenburg; Kenneth Lamb
Journal: J Vet Intern Med Date: 2022-08-16 Impact factor: 3.175

2 in total

Successful management of doxorubicin overdose and extravasation in a dog with lymphoma.

1. Hematologic improvement in dogs with parvovirus infection treated with recombinant canine granulocyte-colony stimulating factor.

2. Acute doxorubicin overdoses.

3. Veterinary cooperative oncology group - common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1.

4. Long-term clinical outcome after accidental overdose of multiple chemotherapeutic agents.

5. Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies.

6. Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial.

7. Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)--a Veterinary Cooperative Oncology Group (VCOG) consensus document.

8. European Oncology Nursing Society extravasation guidelines.

9. Efficacy of intravenous administration of combined acid suppressants in healthy dogs.

Review 10. Dexrazoxane for the treatment of chemotherapy-related side effects.

1. Toxicity, outcome, and management of anthracycline overdoses in 16 dogs.

2. Pharmacokinetic study comparing doxorubicin concentrations after chemoembolization or intravenous administration in dogs with naturally occurring nonresectable hepatic carcinoma.